Best Foundayo (Orforglipron) Providers in 2026 — Ranked & Reviewed

Foundayo (orforglipron) is the first small-molecule (non-peptide) oral GLP-1 receptor agonist FDA-approved for chronic weight management, approved on April 1, 2026 by Eli Lilly. Commercial dispensing started on April 6, 2026 and the provider list is small but growing fast. We track every US telehealth platform and pharmacy confirmed as a Foundayo channel, with pricing tiers verified directly from each provider's website. The Lilly Savings Card brings the price to $25/month for commercially insured patients, $149-$299/month for cash-pay. We update this list weekly as more providers come online.

Lowest ongoing price: $149/mo (LillyDirect Foundayo)

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed

30 foundayo (orforglipron) providers compared · independently scored against our six-factor methodology.

Quick Picks: Top 5

#ProviderScore
1Amazon One MedicalGet started
2FoundGet started
3LillyDirect FoundayoGet started
4Pallas HealthGet started
5ShedRxGet started

Compare the top providers at a glance

Logos, our editorial rating, price, medications, and coverage — the fastest way to narrow the list.

  • ★ Editor's Pick
    Amazon One Medical

    brand-name GLP-1s with published per-dose cash prices and Amazon Pharmacy delivery

    From /mo
    $149medication billed separately
    Coverage
    50 states
    Medications
    OrforglipronSemaglutideTirzepatide
  • Nationwide Coverage
    Found

    medication-included compounded GLP-1 from $169/mo on a 12-month prepaid plan, plus brand insurance help

    From /mo
    $149+ required membership
    Coverage
    50 states
    Medications
    SemaglutideTirzepatideOrforglipron
  • Best Budget

    the cheapest legal brand-name GLP-1

    From /mo
    $149brand-name price
    Scales with dose
    Coverage
    50 states
    Medications
    Orforglipron
  • Transparent Pricing
    Pallas Health

    the most complete public disclosure of pharmacies and prescribing physicians we have found

    From /mo
    $499billed per 4 weeks
    Flat at every dose
    Coverage
    50 states
    Medications
    SemaglutideTirzepatideOrforglipron
  • ShedRx

    compounded GLP-1 as an injection, drops or lozenges, with lower rates on 6- and 12-month plans

    From /mo
    $149+ required membership
    Coverage
    Check intake
    Medications
    SemaglutideTirzepatideOrforglipron
  • PreventiveMD

    flat all-in compounded GLP-1 pricing at every dose, with a choice of named pharmacies

    From /mo
    $198“starting at” price
    Flat at every dose
    Coverage
    43 states
    Medications
    SemaglutideTirzepatideOrforglipron
  • Temi

    comparing partner pharmacies' compounded GLP-1 prices upfront, with no subscription

    From /mo
    $149rises with dose
    Scales with dose
    Coverage
    13 states
    Medications
    SemaglutideTirzepatideOrforglipron
  • GoodRx

    self-pay brand-name Foundayo, Wegovy and Zepbound KwikPen at retail pharmacies

    From /mo
    $149rises with dose
    Scales with dose
    Coverage
    50 states
    Medications
    OrforglipronTirzepatideSemaglutide
6scored dimensions
30foundayo (orforglipron) providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

Detailed Reviews

1

Amazon One Medical

Best for: brand-name GLP-1s with published per-dose cash prices and Amazon Pharmacy delivery

8.5

Amazon One Medical pairs One Medical clinicians with Amazon Pharmacy for brand-name GLP-1s only: Foundayo, the Wegovy pill and pen, and Zepbound. Online On-Demand Care starts at $39 and is cash-pay for medication, while insurance runs through scheduled visits near a One Medical office. Amazon Pharmacy lists cash prices by dose with manufacturer coupons applied, from $149/month for Foundayo or the Wegovy pill and $299 per 28-day Zepbound KwikPen.

Score Breakdown

Value25%
8.5
Effectiveness25%
8.5
User Experience15%
8
Trust & Safety15%
8.8
Accessibility10%
9.5
Support10%
8

Pros

  • ✓Publishes cash prices for every GLP-1 dose up front, with manufacturer coupons applied automatically if eligible
  • ✓Foundayo and the Wegovy pill start at $149/month cash; about $25/month with eligible commercial insurance
  • ✓Brand-name Wegovy, Zepbound and Foundayo prescribed by One Medical clinicians and filled by Amazon Pharmacy
  • ✓Online care from $39 with no One Medical membership required
  • ✓Free delivery through Amazon Pharmacy, with same-day delivery in many cities
  • ✓In-office pharmacist kiosks at select One Medical clinics

Cons

  • ✗Online On-Demand Care is cash-only for medication; insurance needs scheduled visits near a One Medical office
  • ✗You must provide recent lab results (kidney function and glucose or A1c), bought separately if you have none
  • ✗Online program is limited to ages 18-64 and excludes people with diabetes
  • ✗Injectable prices are per 28-day supply, so 13 fills a year, not 12
  • ✗Prices rise with dose, up to $299 for pills and $449 to $499 for Zepbound
  • ✗No compounded options; brand-name only
  • ✗Message follow-up after an On-Demand visit lasts 14 days, then you request a new treatment
Starting from $149/mo (medication billed separately)Read full review →
Get started →
2

Found

Partner

Best for: medication-included compounded GLP-1 from $169/mo on a 12-month prepaid plan, plus brand insurance help

8.3

Found is a weight-care membership that works with many insurance plans for clinical visits and offers a wide medication menu, including non-GLP-1 options. Compounded medication is included in the plan price. Its Offer Terms put compounded semaglutide at $169/mo cash on a 12-month plan paid upfront ($289 month to month) and tirzepatide at $239 ($359), billed every 28 days, while its marketing pages advertise plans from $149/mo cash. Brand GLP-1s such as Wegovy, Zepbound and Foundayo are billed separately from the membership.

Score Breakdown

Value25%
8.5
Effectiveness25%
9
User Experience15%
8
Trust & Safety15%
7.3
Accessibility10%
8.5
Support10%
7.5

Pros

  • ✓Compounded medication included in the plan price
  • ✓Both semaglutide and tirzepatide available
  • ✓Compounded GLP-1 access

Cons

  • ✗The $169 cash rate is a 12-month plan paid upfront; month to month is $289
  • ✗Marketing pages advertise plans from $149/mo cash, but the Offer Terms list semaglutide at $169 and tirzepatide at $239 on 12-month plans
  • ✗Month-to-month plans bill every 28 days, so a year is 13 charges, not 12
  • ✗Brand-name GLP-1 medication is billed separately from the membership
  • ✗Compounded tirzepatide costs more than semaglutide: $239/mo cash on a 12-month plan, $359 month to month
Starting from $149/mo (+ required membership)Read full review →
Get started →
3

LillyDirect Foundayo

Best for: the cheapest legal brand-name GLP-1

8.1

Eli Lilly's manufacturer direct-pay channel for Foundayo (orforglipron), the first oral GLP-1 pill for weight loss. With the Lilly Savings Card, commercially insured patients pay $25/month; cash-pay patients pay $149-$299/month depending on labeled dose. Requires a valid US prescription from any licensed prescriber.

Score Breakdown

Value25%
9
Effectiveness25%
7
User Experience15%
7.5
Trust & Safety15%
9.3
Accessibility10%
9
Support10%
6.5

Pros

  • ✓Cheapest legal path to a brand-name GLP-1 in 2026 ($25/mo with savings card for commercial insurance)
  • ✓Direct from the manufacturer, with no compounding and no third-party reseller
  • ✓Daily oral pill, no injections, no refrigeration
  • ✓Available in all 50 states

Cons

  • ✗Lower mean weight loss than Wegovy (14.9%) and Zepbound (20.9%): labeled-dose 11.1% per Foundayo PI
  • ✗Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
  • ✗$25 savings card requires commercial insurance; Medicare and Medicaid are not eligible
  • ✗Strict empty-stomach 30-minute window may be hard for some patients to follow
Starting from $149/mo (brand-name price)Read full review →
Get started →
4

Pallas Health

Best for: the most complete public disclosure of pharmacies and prescribing physicians we have found

8.1

Pallas Health is a telehealth platform operated by Brentmoor, Inc. offering compounded semaglutide and tirzepatide plus brand-name Wegovy (pen or pill), Foundayo, Zepbound, Ozempic and Mounjaro. Compounded semaglutide is $139 for the first month, then $199 every 4 weeks; tirzepatide is $179, then $299 every 4 weeks, with care, messaging and shipping included and the same price at every dose. Its disclosures page names two physicians with NPIs, the clinical partner Lion MD and seven partner pharmacies.

Score Breakdown

Value25%
7.5
Effectiveness25%
8
User Experience15%
8.5
Trust & Safety15%
8
Accessibility10%
9
Support10%
8

Pros

  • ✓Names seven partner pharmacies with phone numbers and websites, one of the most complete pharmacy disclosures we have seen.
  • ✓Publishes two advising physicians with NPI numbers you can look up yourself in the federal NPI lookup.
  • ✓Price stays the same at every dose, and provider care, check-ins, messaging and shipping are included with no membership fee.
  • ✓Nothing is charged until a clinician prescribes, and you are not charged at all if you are not approved.
  • ✓Offers the Wegovy pill and Foundayo tablets alongside brand-name pens and compounded options, in all 50 states plus DC.

Cons

  • ✗Billed $199 every 4 weeks, not monthly; 13 charges a year make the real cost about $216 a month.
  • ✗The homepage claims "200,000+ patients" while the clinical page describes a July 2026 launch and existing waitlist patients.
  • ✗Once a prescription is issued the current cycle is not prorated or refunded.
  • ✗A live video visit is required in Arkansas, Mississippi, New Mexico, North Dakota, Rhode Island, South Dakota, West Virginia and D.C.
  • ✗The 4.8-star rating does not say which review site it comes from, and the footer says some site content is AI-generated.
Starting from $499/4 wks (billed per 4 weeks)Read full review →
Get started →
5

ShedRx

Partner

Best for: compounded GLP-1 as an injection, drops or lozenges, with lower rates on 6- and 12-month plans

8.0

Telehealth provider offering compounded GLP-1 medications in injectable, lozenge, and drop formats.

Score Breakdown

Value25%
7.5
Effectiveness25%
9
User Experience15%
8
Trust & Safety15%
7.3
Accessibility10%
7.5
Support10%
8

Pros

  • ✓Both semaglutide and tirzepatide available
  • ✓Compounded GLP-1 access
  • ✓Multiple administration formats

Cons

  • ✗Limited public information on program details, and the compounding pharmacies are not named
  • ✗The category page lists Wegovy and Zepbound from $349/month; their product pages say $149-$199 and $299 plus a $125/month membership
  • ✗The 120-day guarantee covers only first-time users of the drug class who complete four member commitments
Starting from $149/mo (+ required membership)Read full review →
Get started →

Full ranking: all 30 foundayo (orforglipron) providers

In ranked order. Score is out of 10; each name opens the full review.

  1. 1Amazon One Medical8.5$149/mo (medication billed separately)Visit site →
  2. 2FoundPartner8.3$149/mo (+ required membership)Get started →
  3. 3LillyDirect Foundayo8.1$149/mo (brand-name price)Visit site →
  4. 4Pallas Health8.1$499/4 wks (billed per 4 weeks)Visit site →
  5. 5ShedRxPartner8.0$149/mo (+ required membership)Get started →
  6. 6PreventiveMD7.8$198/mo (“starting at” price)Visit site →
  7. 7Temi7.8$149/mo (rises with dose)Visit site →
  8. 8GoodRx7.8$149/mo (rises with dose)Visit site →
  9. 9Imbue Health7.8$149/mo (+ required membership)Visit site →
  10. 10RoPartner7.7$149/mo (+ required membership)Get started →
  11. 11Gentle Health7.6—Visit site →
  12. 12MaximusPartner7.6$200/mo (starting dose)Get started →
  13. 13WeightWatchers7.6$149/mo (+ required membership)Visit site →
  14. 14Alloy7.5$248/mo (starting dose)Visit site →
  15. 15Hers7.5$149/mo (+ required membership)Visit site →
  16. 16Phoenix NP7.4$248/4 wks (billed per 4 weeks)Visit site →
  17. 17Kin Meds7.4—Visit site →
  18. 18Bayan Health7.3$199/moVisit site →
  19. 19BloomWell Rx7.3—Visit site →
  20. 20HuHealth7.3$149/mo (see plan details)Visit site →
  21. 21PrideRx7.2$149/mo (+ required membership)Visit site →
  22. 22Médetone7.2$149/mo (+ required membership)Visit site →
  23. 23Tummala Health7.2—Visit site →
  24. 24Walgreens Weight Management7.1$149/mo (medication billed separately)Visit site →
  25. 25Healthspan7.1$149/mo (+ required membership)Visit site →
Show the remaining 5 providers
  1. 26Hims7.1$149/mo (+ required membership)Visit site →
  2. 27Heva Health7.0—Visit site →
  3. 28Näky7.0$424/mo (+ added fee)Visit site →
  4. 29NowPatient6.9—Visit site →
  5. 30ZipHealth6.7$149/mo (see plan details)Visit site →

How to choose a Foundayo (orforglipron) provider

Foundayo is the first small-molecule (non-peptide) oral GLP-1 pill for weight loss, and the dispensing channel is new and small. Because it's a brand-name Lilly product, the differences between providers are about access, price, and legitimacy — not the medication itself.

What to look for

  • Verified Foundayo channel. Foundayo is dispensed through specific pharmacies. Confirm the provider is an actual verified channel for the FDA-approved product — not a compounded 'orforglipron' substitute, which isn't a legitimate thing.
  • Lilly Savings Card eligibility. For eligible commercially insured patients, the manufacturer savings card can dramatically lower the monthly cost. Ask whether the provider applies it.
  • Real clinical intake. As a genuine prescription medication, Foundayo requires a proper medical review. Favor providers with a reachable clinician over instant-approval storefronts.

Red flags to avoid

  • No named pharmacy or LegitScript listing. A legitimate compounded-GLP-1 provider names its 503A/503B pharmacy partner and carries LegitScript certification. If neither is disclosed, you can't verify what you're injecting.
  • Async-only, no real clinician review. A prescriber should review your intake and be reachable for dose questions. Instant approval with no way to reach a clinician is a safety gap.
  • Teaser pricing that hides the real cost. A low 'first month' price that jumps at higher doses, or a membership fee stacked on top of the medication, can double the true monthly total. Confirm the ongoing, all-in price before you pay.
  • Weight-loss claims for B12, MIC, or HCG shots. Only GLP-1 injections have trial evidence for weight loss. A clinic selling B12, lipotropic, or HCG shots as a weight-loss treatment is a red flag.

Every provider ranked above is scored against these criteria across our six-dimension methodology, and prices are re-verified against each provider’s live site.

How we rank & what counts as “legit”

Every provider in this ranking is scored against our published six-factor rubric[1] — value, effectiveness, user experience, trust & safety, accessibility, and support.

Brand-name Wegovy, Zepbound, Ozempic, and Mounjaro are separately FDA-approved under their own NDA numbers[4][5]. Published Phase 3 efficacy for semaglutide 2.4 mg (~14.9% mean weight loss over 68 weeks) comes from the STEP 1 trial[6], and for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) from SURMOUNT-1[7]; the SURMOUNT-5 head-to-head published in 2025 compared the two directly[8].

Insurance coverage for anti-obesity medications varies widely by state Medicaid program and commercial plan[9][10]. Compounded and brand-name GLP-1s are generally FSA/HSA eligible with a prescription under IRS Publication 502[11].

Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Frequently Asked Questions

In Eli Lilly's Phase 3 program, once-daily oral orforglipron produced an average weight loss of about 11–12% at the highest dose over roughly 72 weeks. That's less than injectable tirzepatide (~21%) but comparable to injectable semaglutide, in a needle-free daily pill — Foundayo was FDA-approved for chronic weight management in 2026.
Yes. Foundayo (orforglipron) received FDA approval and commercial dispensing began in 2026. The provider list above tracks the verified US telehealth platforms and pharmacies confirmed to dispense it, with pricing; the channel is small but expanding, and the Lilly Savings Card can lower the cost for eligible insured patients.
It's the most effective FDA-approved oral GLP-1 for weight loss to date — a genuine once-daily pill, unlike oral semaglutide (Rybelsus/oral Wegovy), which has strict food-and-water timing. Injectable tirzepatide still produces more weight loss overall, so 'strongest' depends on whether you want a pill or an injection.
Each provider is evaluated across six weighted dimensions: Value (25%), Effectiveness (25%), User Experience (15%), Trust & Safety (15%), Accessibility (10%), and Support (10%). We research publicly available information, user reviews, clinical evidence, and pricing data, then compute a weighted overall score out of 10.
Each provider's score is computed independently using the six-dimension methodology, and a commercial relationship never changes a provider's underlying score — you can see every provider's full score on its card. Some providers have affiliate agreements with us, meaning we earn a commission if you click through and make a purchase. On our highest-commercial-intent lists — including the semaglutide, tirzepatide, compounded and cheapest molecule lists, the weight-loss injection and shot lists, and the fitness-app list — we feature affiliate partners in the top positions; on every other list the order follows the score (or, for the cheapest lists, the lowest price) directly. This placement is disclosed here and on our methodology and affiliate-disclosure pages.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  5. 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  8. 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
  9. 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  10. 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
  11. 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.